OTTOBOCK HUMAN MOBILITY acquired by DHCARE
Context
DHCare has entered into an agreement to acquire Ottobock's Human Mobility business, which specializes in manual and power wheelchairs, as well as pediatric mobility solutions. This transaction is part of Ottobock's strategy to refocus its resources on its core, high-growth businesses, including prosthetics, neuro-orthotics, and exoskeletons. The divested business generates approximately €80 million in annual revenue, employs around 270 staff members, and comprises the German Human Mobility companies, as well as veldink4Kids, a Dutch specialist in pediatric wheelchairs. For DHCare, this acquisition represents a major strategic milestone and its first since the group's reorganization under its new shareholder structure. The deal significantly expands DHCare's mobility solutions portfolio and strengthens its presence in several key European markets, particularly in the DACH region, where Human Mobility has a long-standing strong position. By combining their expertise, DHCare and Human Mobility aim to create a pan-European platform that can offer an expanded range of clinical solutions, technical services, and after-sales support to patients, healthcare professionals, and payers. The transaction is expected to be completed in the second half of 2026.
OTTOBOCK HUMAN MOBILITY, which reported an EBITDA margin of in 2025, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.5x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Human Mobility is Ottobock's dedicated business unit for wheelchairs and mobility solutions. The company designs, manufactures, and markets a comprehensive range of equipment aimed at enhancing the independence and quality of life of individuals with permanent or temporary functional limitations. Its portfolio includes manual and power wheelchairs, specialized seating systems, rehabilitation strollers, and pediatric mobility solutions for children with complex needs. The company has particular expertise in high-end motorized wheelchairs and customized devices designed to address demanding clinical situations. Headquartered in Germany with complementary activities in the Netherlands through veldink4Kids, Human Mobility has a strong presence in German-speaking countries and a solid reputation among specialized healthcare professionals in rehabilitation, neurology, and orthopedics. Its business model is built on close collaboration with therapists, rehabilitation centers, specialized distributors, and reimbursement agencies to provide tailored solutions that meet the specific needs of users.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2026 | YOTTA CAPITAL / OUEST CROISSANCE | Les Laboratoires Herbolistique | FRANCE | Nutrition & Dietary Supplements |
| 07/2026 | BAIN CAPITAL | Vitabiotics | UNITED KINGDOM | Nutrition & Dietary Supplements |
| 06/2026 | 3I | LABORATOIRE NUTERGIA | FRANCE | Nutrition & Dietary Supplements |
| 06/2026 | CORDENPHARMA | AMBIOPHARM | UNITED STATES | CDMO |
| 06/2026 | BRIDGEPOINT | OBAGI MEDICAL | UNITED STATES | Generics / Labs |
| 06/2026 | ABBVIE | APOGEE THERAPEUTICS | UNITED STATES | R&D Biotech |
| 06/2026 | MOTION EQUITY PARTNERS | POLARIS | FRANCE | Nutrition & Dietary Supplements |
| 06/2026 | COLUMBUS VENTURE PARTNERS / MERIEUX EQUITY PARTNERS | ONA THERAPEUTICS | SPAIN | R&D Biotech |
| 05/2026 | STRYKER | AMPLITUDE VASCULAR SYSTEMS | UNITED STATES | Medical Devices |
| 04/2026 | HALMA | SURGISTAR | UNITED STATES | Medical Devices |
REFERENCES
Revenue range: 50M - 100M EUR
EBITDA range: 5M - 25M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of OTTOBOCK HUMAN MOBILITY by DHCARE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: dhcare